These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3783906)

  • 41. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
    Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
    Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic tests for familial hypercholesterolemia.
    Day I; Humphries S
    Nat Biotechnol; 1996 Oct; 14(10):1227-8. PubMed ID: 9631083
    [No Abstract]   [Full Text] [Related]  

  • 43. Hyperlipidemia and cardiovascular disease with focus on familial hypercholesterolemia.
    Holven KB; Ulven SM; Bogsrud MP
    Curr Opin Lipidol; 2017 Oct; 28(5):445-447. PubMed ID: 28857860
    [No Abstract]   [Full Text] [Related]  

  • 44. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autosomal recessive hypercholesterolemia in three sisters with phenotypic homozygous familial hypercholesterolemia: diagnostic and therapeutic procedures.
    Thomas HP; Vogt A; Wilund KR; Schliesser C; Steinhagen-Thiessen E; Kassner U
    Ther Apher Dial; 2004 Aug; 8(4):275-80. PubMed ID: 15274677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and treatment of heterozygous familial hypercholesterolemia in children and adolescents.
    Kwiterovich PO
    Am J Cardiol; 1993 Sep; 72(10):30D-37D. PubMed ID: 8213494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.
    Civeira F;
    Atherosclerosis; 2004 Mar; 173(1):55-68. PubMed ID: 15177124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Genetic Diagnosis in Familial Hypercholesterolemia - yes].
    März W
    Dtsch Med Wochenschr; 2017 May; 142(9):687-688. PubMed ID: 28454203
    [No Abstract]   [Full Text] [Related]  

  • 50. [Genetic principles of food related problems--familial hypercholesterolaemia].
    Floré M; Robberecht N; Hermans H
    J Pharm Belg; 2012 Mar; (1):18-21. PubMed ID: 22536679
    [No Abstract]   [Full Text] [Related]  

  • 51. Guidelines for the management of familial hypercholesterolemia.
    Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S
    J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Biotechnology and familial hypercholesterolemia].
    Tonstad S
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3124. PubMed ID: 9381451
    [No Abstract]   [Full Text] [Related]  

  • 53. [Diagnostic and functional significance of arcus lipoides in hypercholesterolemia].
    Schneider T; Ulbig M
    Fortschr Ophthalmol; 1991; 88(1):21-4. PubMed ID: 2045021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of gene mutations allows for the molecular diagnosis of familial hypercholesterolemia.
    Retief AE; Kotze MJ; Oosthuizen CJ
    S Afr Med J; 1989 Aug; 76(3):121. PubMed ID: 2762943
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe familial hypercholesterolaemia: current and future management.
    Farnier M; Bruckert E
    Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-filtration plasmapheresis in heterozygous familial hypercholesterolemia: our experience over 25 treatments.
    Candrina R; Spandrio S; Di Stefano O; Scalvini T; Cotelli M; Tosoni M; Giustina G
    Beitr Infusionsther; 1988; 23():189-90. PubMed ID: 2484776
    [No Abstract]   [Full Text] [Related]  

  • 57. The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population.
    Damgaard D; Larsen ML; Nissen PH; Jensen JM; Jensen HK; Soerensen VR; Jensen LG; Faergeman O
    Atherosclerosis; 2005 May; 180(1):155-60. PubMed ID: 15823288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid Screening in Children.
    Daniels SR
    J Am Coll Cardiol; 2015 Sep; 66(11):1258-1260. PubMed ID: 26361157
    [No Abstract]   [Full Text] [Related]  

  • 59. Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
    Knowles JW; Rader DJ; Khoury MJ
    JAMA; 2017 Jul; 318(4):381-382. PubMed ID: 28742895
    [No Abstract]   [Full Text] [Related]  

  • 60. Current familial hypercholesterolemia diagnostic criteria underdiagnose APOB mutations: Lessons from the Amish community.
    Andersen L; Ibarra J; Andersen R
    J Clin Lipidol; 2016; 10(2):443-4. PubMed ID: 27055977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.